Cocaine use disorder (CUD) is a clinically recognized brain disorder that causes compulsive cocaine use despite serious physical, mental, and social consequences.
Evidence-based rehab combines proven behavioral therapies with individualized care to reduce cocaine use, manage co-occurring mental health conditions, and support sustained recovery.
No FDA-approved medication for CUD currently exists, but behavioral treatment works. People who engage in structured, evidence-based programs achieve meaningful reductions in cocaine use and improved quality of life.
Cocaine is a powerful stimulant that floods the brain’s reward system with dopamine, producing short bursts of euphoria followed by a rapid crash. It is snorted, smoked (as crack cocaine), or injected. Binge use is common, with people repeatedly using it for hours or days to avoid withdrawal.
In 2022, about 5.3 million Americans aged 12 or older used cocaine in the past year, and about 1.4 million met criteria for cocaine use disorder [1]. Cocaine is the most commonly used illicit stimulant in the United States and the second leading cause of illicit drug overdose death, particularly when combined with opioids such as fentanyl.
Chronic use raises the risk of heart attack, stroke, and cardiac arrhythmia and causes neurological changes that impair memory and decision-making. Socially, cocaine use is linked to job loss, family breakdown, legal problems, and homelessness.
Evidence-based treatment for cocaine use disorder refers to therapies proven in rigorous clinical trials to reduce cocaine use or improve recovery outcomes. This is not one single program. It is a combination of therapies matched to the person’s specific needs and circumstances.
The National Institute on Drug Abuse (NIDA) defines evidence-based treatment as care that may be delivered in outpatient, intensive outpatient, inpatient, or residential settings, depending on what a person needs.
Most people with CUD begin with outpatient or intensive outpatient care. Residential or inpatient treatment is recommended when someone needs medical supervision, has a high relapse risk, or lacks a stable living environment [2].
The table below summarizes the main levels of care used in cocaine addiction treatment.
| Level of Care | Setting | Who It Suits |
| Standard Outpatient | 1-2 sessions per week | Mild to moderate CUD with stable support |
| Intensive Outpatient (IOT) | Multiple sessions, several hours per week | Moderate CUD; most common initial level |
| Residential | Live-in program, weeks to months | Severe CUD or unstable living environment |
| Inpatient / Hospital | 24-hour medical supervision | Medical complications or co-occurring crisis |
People often move through more than one level of care over the course of treatment, stepping down as they stabilize.
Two behavioral therapies stand out in the clinical evidence for cocaine use disorder: Contingency Management and Cognitive Behavioral Therapy. They are often used together.
CM uses small, tangible rewards such as gift cards or prize drawings to reinforce drug-free urine tests. It draws on the principle that behavior responds to real-world consequences. In a landmark meta-analysis of 157 clinical trials and nearly 16,000 participants, only contingency management programs were significantly associated with an increased likelihood of cocaine-negative urine tests across all treatment groups. CM is now recognized as a current standard of care for stimulant use disorders in adults [3].
CBT teaches people to identify high-risk situations that trigger cocaine use, challenge the thinking that drives it, and build coping skills. A 2023 systematic review found that CBT produced small to moderate effects on substance use compared to inactive treatment, with effects strongest at one to six months after treatment. The benefits of CBT tend to improve over time, which makes it especially helpful for preventing relapse in the long term [4].
These two approaches complement each other. CM builds early momentum by reducing cocaine use quickly. CBT builds the internal skills needed to maintain that progress over time. Programs that combine both therapies typically achieve better outcomes than either one alone [5].
Research helps us understand what makes treatment more or less likely to succeed. Knowing these factors allows clinicians to tailor care and enables patients to be realistic and proactive.
A 2024 systematic review of 32 randomized controlled trials identified younger age, extended cocaine use history, and elevated craving levels as significant predictors of relapse and dropout. Early abstinence and strong treatment engagement were associated with better long-term outcomes [6]. Factors that improve the chances of success include:
Most people seeking treatment for cocaine use disorder also live with at least one other mental health condition. This is not unusual, and it does not disqualify someone from treatment. It means treatment needs to address both at the same time.
Studies of people seeking cocaine treatment have found that between 65% and 73.5% have a co-occurring lifetime mental health diagnosis. Current cocaine use is associated with nearly triple the risk of depression and more than double the risk for anxiety disorders compared to non-users. PTSD, bipolar disorder, and ADHD are also common [5].
According to NIDA, 35% of adults in the U.S. with a mental health disorder also have a substance use disorder. Mental health disorders commonly co-occurring with substance use disorders include anxiety, depression, PTSD, and bipolar disorder.
Integrated treatment, meaning care that addresses both the substance use disorder and the mental health condition from the same clinical team, produces the best outcomes [7].
If you are entering cocaine treatment and have symptoms of depression, anxiety, or trauma, tell your treatment team. These conditions are treatable, and addressing them improves recovery outcomes. They are part of the picture, not a barrier to care.
For those seeking this level of specialized, integrated care in the San Francisco Bay area, Alta Mira Recovery Programs is a high-end, top-tier residential addiction center specializing in the treatment of substance use disorders and complex co-occurring mental health issues.
Contact our compassionate admissions team to learn more.
| [1] | Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. U.S. Department of Health and Human Services, Center for Behavioral Health Statistics and Quality. |
| [2] | National Institute on Drug Abuse. (2024). Treatment. National Institutes of Health. |
| [3] | Bentzley, B. S., et al. (2021). Comparison of treatments for cocaine use disorder among adults: A systematic review and meta-analysis. JAMA Network Open, 4(5), e218049. |
| [4] | Boness, C. L., et al. (2023). An evaluation of cognitive behavioral therapy for substance use disorder: A systematic review and application of the Society of Clinical Psychology criteria for empirically supported treatments. Clinical Psychology: Science and Practice, 30(2), 129–142. |
| [5] | McHugh, R. K., et al. (2022). Cocaine use disorder (CUD): Current clinical perspectives. Substance Abuse and Rehabilitation, 13, 79–96. |
| [6] | Palazón-Llecha, A., et al. (2024). Predictors of cocaine use disorder treatment outcomes: A systematic review. Systematic Reviews, 13(1), 124. |
| [7] | National Institute on Drug Abuse. (2024). Co-occurring disorders and health conditions. National Institutes of Health. |
